# Oral or Intra Muscular Vitamin D2 Vs Oral or Intra Muscular Vitamin D3 in Treatment of Vitamin D Deficiency

> **NCT06618365** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Hamad Medical Corporation** · enrollment: 100 (estimated)

## Conditions studied

- Vitamin D Deficiency

## Interventions

- **DRUG:** Vitamin D Deficiency

## Key facts

- **NCT ID:** NCT06618365
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-02
- **Primary completion:** 2025-07
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618365, "Oral or Intra Muscular Vitamin D2 Vs Oral or Intra Muscular Vitamin D3 in Treatment of Vitamin D Deficiency". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06618365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*